New studies are exploring the potential link between Ozempic and cancer, with one study suggesting a 30% lower risk of breast cancer for GLP-1 users. Other research indicates that negative body image after weight loss can lead users to discontinue GLP-1 drugs.

Peloton is launching a new strategy for its comeback, targeting users of GLP-1 weight-loss drugs and expanding its treadmill offerings.

The increasing use of GLP-1 drugs is reportedly influencing consumer behavior, leading to a resurgence in in-store clothes shopping among users.

J.P. Morgan upgraded Cheesecake Factory's stock, citing the restaurant chain's ability to cater to a diverse customer base, including those using weight-loss drugs (GLP-1 users), amidst a cautious consumer environment.

GLP-1 medications have transformed weight loss, but their appetite-suppressing effects can lead to reduced food intake. Experts suggest specific supplements to address potential nutritional gaps.

Users of GLP-1 weight-loss drugs are reportedly reducing their restaurant spending, leading to a noticeable impact on the restaurant industry's business performance.